TL011

· Teva Pharmaceutical Industries, Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TL011, covering 2021-10-04 to 2021-10-04. Get the full timeline:

Most recent: Clinical Trial Update: TL011 in Severe, Active Rheumatoid Arthritis Patients [Phase 1]